SCHEMBL4137428

SCHEMBL4137428

COc1ccc(/C=C2\SC(=S)N(Cc3ccc4c(c3)OCO4)C2=O)cn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 4/20 0.57
▸ MAPT P10636 4/20 0.52
▸ MEN1 O00255 8/20 0.50
▸ KMT2A Q03164 8/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ PKM P14618 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ HSD17B3 P37058 1/20 0.48
▸ POLB P06746 4/20 0.47
▸ ATM Q13315 1/20 0.47
▸ CFTR P13569 1/20 0.47
▸ PSMD14 O00487 1/20 0.46
▸ BLM P54132 1/20 0.46
▸ CTDSP1 Q9GZU7 1/20 0.46
▸ PTPN2 P17706 1/20 0.45
▸ PTPN1 P18031 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4137433 1.00 MAPK1 (0.57) MAPK1MAPTMEN1KMT2AL3MBTL1
SCHEMBL4137558 0.88 MAPK1 (0.60) MAPK1MAPTMEN1KMT2ATDP1
SCHEMBL13651165 0.88 MAPK1 (0.60) MAPK1MAPTMEN1KMT2ATDP1
SCHEMBL4137556 0.88 MAPK1 (0.60) MAPK1MAPTMEN1KMT2ATDP1
SCHEMBL4132883 0.87 MAPT (0.64) MAPK1MAPTMEN1KMT2AL3MBTL1
SCHEMBL4132886 0.87 MAPT (0.64) MAPK1MAPTMEN1KMT2AL3MBTL1
SCHEMBL4138637 0.85 MAPK1 (0.72) MAPK1MAPTMEN1KMT2APKM
SCHEMBL4138638 0.85 MAPK1 (0.72) MAPK1MAPTMEN1KMT2APKM
SCHEMBL4130334 0.85 MAPK1 (0.60) MAPK1MAPTMEN1KMT2AL3MBTL1
SCHEMBL4130332 0.85 MAPK1 (0.60) MAPK1MAPTMEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247516-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS KOTNIK MIHA 2009-10-01 — — US disclosed
US-20090247516-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS KOTNIK MIHA 2009-10-01 — — US disclosed
EP-1916249-A1 3-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-ylidene derivatives as antibacterial agents LEK Pharmaceuticals D.D. (SI) 2008-04-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247516-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS XDH, TXLNA, Q6ZSR9 MAPK1 3035/4885MAPT 4768/4885MEN1 2336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback